Association Between the COVID-19 Pandemic and Maternal Outcomes: A Population-based Study from Alabama

Sunday, April 24, 2022

8:30 AM – 8:45 AM US MT

Location: Convention Center: 605

Publication Number: 2175.3

Vivek V. Shukla, University of Alabama at Birmingham, Birmingham, AL, United States; AKM F. Rahman, University of Alabama at Birmingham, Vestavia, AL, United States; Xuejun Shen, Alabama Department of Public Health, Montgomery, AL, United States; Allison Black, University of Alabama School of Medicine, Mountain Brk, AL, United States; Arie Nakhmani, University of Alabama at Birmingham, Birmingham, AL, United States; Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States; Waldemar A. Carlo, University of Alabama at Birmingham, Birmingham, AL, United States

Presenting Author(s)

Vivek V. Shukla, MD
Assistant Professor
University of Alabama at Birmingham
Birmingham, Alabama, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Vivek V. Shukla, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

AKM F. Rahman, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Xuejun Shen, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Allison Black, Md: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Arie Nakhmani, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Namasivayam Ambalavanan, MBBS MD: ● ProvePharm (Currently Ongoing) (Products/Services: Consultant).
● Radiometer (Currently Ongoing) (Products/Services: Consultant).
● ResBiotic (Currently Ongoing) (Products/Services: Advisory Committee).
● Shire (Currently Ongoing) (Products/Services: Consultant).

Waldemar A. Carlo, MD: ● Mednax (Currently Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).